Christian E. Elling heads the early stage biotech investment unit Lundbeckfonden Emerge. He is a member of the board of directors of IO Biotech, NMD Pharma, Afyx Therapeutics, SNIPR Biome, Folium and former member of the board of directors of EpiTherapeutics and Inagen.
Christian was previously co-founder, Vice President of Biology and Development and later CEO of 7TM Pharma. Christian received his early training in biochemistry and received his PhD in pharmacology from University of Copenhagen, Denmark.
Direct +45 3912 8090
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.